Search In this Thesis
   Search In this Thesis  
العنوان
Endoglin as a Novel Serum Marker for Hepatocellular Carcinoma in patients with Kiver cirrhosis /
المؤلف
Elbedewy, Marwa Mohammed Salah.
هيئة الاعداد
باحث / مروه محمد صلاح البديوى
مشرف / احمد مصطفى امين
مشرف / احمد خالد توقيق
مشرف / امل عبد الرشيد وافى
الموضوع
Microbiology & Immunology.
تاريخ النشر
2015.
عدد الصفحات
p 128. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
علم الأحياء الدقيقة (الطبية)
تاريخ الإجازة
1/1/2015
مكان الإجازة
جامعة طنطا - كلية الطب - ميكروبيولوجيا الطبيه والمناعه
الفهرس
Only 14 pages are availabe for public view

from 16

from 16

Abstract

Hepatocellular carcinoma is a major cause of morbidity and mortality in
Egypt,The incidence of HCC is rising worldwide being currently the fifth most common cancer and third cause of cancer-related mortality . Its prognosis is poor and early detection is important to improve the prognosis
Alpha-fetoprotien (AFP) has been used as a serum marker for HCC for many years.AFP level may be normal in up to 40% of patients with HCC and elevated AFP level may be also seen in patients with cirrhosis or exacerbation of chronic hepatitis Endoglin and IL-6 have been identified in the serum of patients with hepatocellular arcinomas, and can be used as serological markers for the diagnosis of hepatocellular carcinoma. Hence, Endoglin and IL-6 are
promising new serum markers for HCC. The aim of The present study was to evaluate the diagnostic value of
serum Endoglin level and serum IL-6 level in HCC patients with underlying
cirrhosis compared to AFP which is the reference marker for HCC. This study was carried on total number of 70 subjects including 60 patients selected from inpatients and outpatients who attended Tropical Medicine Department in Tanta University